{"name":"XtalPi","slug":"xtalpi","ticker":"PRIVATE","exchange":"Private","domain":"xtalpi.com","description":"XtalPi Holdings Limited is a publicly listed Chinese biotechnology company that engages in research and development for early-stage drug discovery and material science through methods backed by artificial intelligence (AI).","hq":"Shenzhen, China","founded":0,"employees":"","ceo":"Shuhao Wen","sector":"AI Drug Discovery / Computational Chemistry","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$2B (last private valuation)","metrics":{"revenue":100000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"XtalPi-101 patent cliff ($500M at risk)","drug":"XtalPi-101","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-15","type":"deal","headline":"XtalPi Raises $100M in Series C Funding","summary":"XtalPi secured $100 million in Series C funding to accelerate its AI-driven drug discovery efforts.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"trial","headline":"XtalPi's Lead Candidate Enters Phase 2 Clinical Trials","summary":"XtalPi's lead candidate, a potential treatment for a rare neurological disorder, has entered Phase 2 clinical trials.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxPS1RXYjRiOGNYNTVtdHJoMDVWZ0E2N19kZFB2T0xUU2VnSEhwTURPV01aWHllVy1EWVBVTTVTZFJzRncyakloTlV3SzNYRDJPZkRuTnIxdndVckZMMkNfczVPY1hXRWlzNDRvWWhTZTg3ejI5QWdzbExPdy1LSXd2R2hCWUQ1VllHWHpTOGk5R1JwakpuOHN1QWo0WjFMcG5mRnU4Yl8tbGFsR0FudFBnRXpQcjNhSm54ZXhNeFhKY2RVemhYT1EyUkhFRUtvQURKT29DWkkwSkc2VHdfc2tfUDR6eEFHdXNOQVFrVnBNWXpValJ0U2xzbnFpU1d5TWxvN0RfM0g3cVNxMkpvVnkyVC13YnlPQ3FGSkZz?oc=5","date":"2025-09-09","type":"regulatory","source":"PR Newswire","summary":"XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals - PR Newswire","headline":"XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5oSk1kU1ozNWc4QWxjUFFvbFZvbmtQaUdRNkVyZ0FyZFFuYnZrM3hoYXczd3V2bW1qdEpoUFBseG1WM3JrSXgwSDFhclU5eUI3ck9oQmZjN1ZjR3ZMR2tILURIVVdpeVFYWlNsQzk3MzBwNEV5X2xrcTVGRE4tUQ?oc=5","date":"2025-08-06","type":"deal","source":"Rest of World","summary":"China’s AI drug discovery companies land huge deals with Big Pharma - Rest of World","headline":"China’s AI drug discovery companies land huge deals with Big Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQbUV0Y0Z6eDlRVGQ0bVdtd0NyT1BlZ05IVHJ4aGViU21PMVRLWWFybTBCOEVMZmprZzNKaFR6TDRIUUdFVTRsLXpzMl81aWVxaXl1VThjQmVsYU9MYzg1SjFnSnlvaGxjV3M2b1NZdVY4YWlLN25SbllfUjE4ZFdJb0h6T0JleV9xMnBYVFJNSUdkdUg4d1NSd1VGQWQ1YmRZM19GZ09FVU9GNlFx?oc=5","date":"2025-02-10","type":"pipeline","source":"Inside Precision Medicine","summary":"5 Key AI Players Leading the Drug Discovery Push - Inside Precision Medicine","headline":"5 Key AI Players Leading the Drug Discovery Push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOSlRvRjRhby1aUmk1WXVDUkFwd2FJclpLc1lRRjhjY0ozeGh5VXNaVzlZakFuNFFPMURyN2JnZ2g0OC1Va01rbGJQMnhkblZWRjNuY0FkUDhHaFlfUzU5WnRhcVNpMG5ucjVsWEpIWkEzWnBQQ3dZU3hRVEh3YzZCMzNFX0I?oc=5","date":"2025-02-03","type":"pipeline","source":"statnews.com","summary":"DeepSeek signals China’s rising influence in AI — and AI drug development - statnews.com","headline":"DeepSeek signals China’s rising influence in AI — and AI drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOaG5oYmUxOXdlRFRRQXMydEc0emVSWXhMUV9CSmJmMUdMUkVKSElaZjlOQmRVeXBOU1lia3huTl90d2wtS2lVSVpYb0Z2eWdoSG5Mb2hDbURrOUFiTFRjMmlvNnFaSGFRazZOekVvb1c0ck5sMnJLYWZ4dHhaMFVVYW9qWU5HTGNZU194S0wtaw?oc=5","date":"2024-05-29","type":"pipeline","source":"drugdiscoverytrends.com","summary":"100 of the best-funded private healthcare and biotech companies - drugdiscoverytrends.com","headline":"100 of the best-funded private healthcare and biotech companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOOTJNRVFRWG40QjBMOVBZTEE0Y25KNGl2U08zOERVNHc4d0NndXlhb2wybVhmZkt0MVlmWEFTZm5rRW9mZGk5aUI1ZGYtZGFVVVJBdTA0RmxqWFRDRzhZcURhZldzbUpEbHRHTlJyRVFRMkxzWlJvbF9FUFJsNklSREpiR2ZuSnNvOGxlcnVnQkQ1NGxNbTRDaExuSVdKN1UwczVLT0xGVUlqenBJUlBTZTRFaWJfNmxQR3d5S3RlYw?oc=5","date":"2023-12-01","type":"pipeline","source":"Forbes","summary":"Tencent-Backed AI Drug Discovery Startup Xtalpi Files For Hong Kong IPO - Forbes","headline":"Tencent-Backed AI Drug Discovery Startup Xtalpi Files For Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxOT0s3VWd0RGQtTWp1TzYxeXNRU2UyMkJfSjJ0dVE2aTlyVGlSTnBxbDI0ejNNblZQZ1psVXFLOTNNdGxDVWRnTXY4SDJmLWQtVXB1UnF5c09sNU1mTG50dzE3bDk1cmc2MzRiVi0zZW5ZNHczeEljYXhfNk4zSzA0Q2EyTVQwZDNuUERTaldUc04zNm05MEdvOGpTUWRSZWxmdmtEZG5HMlBTLXZNQTNHQjloRm9tZmo5V0xtalEySGFLeDJUaTJ3VVZHYzBCZnJWYTlpMWE2WktKdi1EWXRJQlZjQWpGRDk1ZGxnRFJmT3I?oc=5","date":"2023-05-30","type":"deal","source":"Forbes","summary":"Sequoia China-Backed AI Startup Xtalpi To Partner With Pharma Giant Eli Lilly In $250 Million Novel Drug Deal - Forbes","headline":"Sequoia China-Backed AI Startup Xtalpi To Partner With Pharma Giant Eli Lilly In $250 Million Novel Drug Deal","sentiment":"neutral"}],"patents":[{"drugName":"XtalPi-101","drugSlug":"generic-name-not-disclosed","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":500000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Pfizer","Merck","Bristol-Myers Squibb"],"therapeuticFocus":["Oncology","Neurology"],"financials":null,"yahoo":null}